MALAT1 rs619586 polymorphism functions as a prognostic biomarker in the management of differentiated thyroid carcinoma

MLA

Jun‐xiao Liu, and Meng‐li Wang. “MALAT1 Rs619586 Polymorphism Functions as a Prognostic Biomarker in the Management of Differentiated Thyroid Carcinoma.” Journal of Cellular Physiology, vol. 235, no. 2, Apr. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b36a753672b07e2bbf4a1582d23eb458&authtype=sso&custid=ns315887.

APA

Jun‐xiao Liu, & Meng‐li Wang. (2019). MALAT1 rs619586 polymorphism functions as a prognostic biomarker in the management of differentiated thyroid carcinoma. Journal of Cellular Physiology, 235(2).

Chicago

Jun‐xiao Liu, and Meng‐li Wang. 2019. “MALAT1 Rs619586 Polymorphism Functions as a Prognostic Biomarker in the Management of Differentiated Thyroid Carcinoma.” Journal of Cellular Physiology 235 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b36a753672b07e2bbf4a1582d23eb458&authtype=sso&custid=ns315887.